Verge Genomics to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023 Press ReleaseRob MaguireJanuary 4, 2023
Verge Genomics Appoints Diego Cadavid, M.D., as Chief Medical Officer Press ReleaseRob MaguireDecember 6, 2022
Alice Zhang to present at Emergent BioSolutions "Horizon Talks" Series EventsRob MaguireNovember 29, 2022
CEO Alice Zhang to present at the 5th Annual Evercore ISI HealthCONx Conference 2022 EventsRob MaguireNovember 21, 2022
CEO Alice Zhang to present at the Piper Sandler 34th Annual Healthcare Conference EventsRob MaguireNovember 21, 2022
VERGE GENOMICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN NOVEMBER Press ReleaseRob MaguireNovember 21, 2022
Alice Zhang, CEO & Co-founder of Verge Genomics, Recognized Today by Both Fortune and Fierce Biotech as a Pioneer in AI-Driven Drug Discovery Press ReleaseRob MaguireNovember 14, 2022
Verge Genomics Initiates First-In-Human Dosing in Phase 1 Trial of VRG50635, A Novel Therapeutic for Amyotrophic Lateral Sclerosis Press ReleaseRob MaguireOctober 31, 2022
Q&A // Emerging biotech Verge Genomics’ Alice Zhang on a young biotech founder’s ‘superpower’ and going from target to drug NewsRob MaguireOctober 27, 2022
Verge Genomics Appoints John Applegate as Chief Financial Officer Press ReleaseRob MaguireOctober 17, 2022
Goldman Sachs Honors Verge Genomics for Entrepreneurship as the 2022 Builders and Innovators Summit EventsRob MaguireOctober 12, 2022
Verge Genomics Honored by Goldman Sachs for Entrepreneurship Press ReleaseRob MaguireOctober 12, 2022
'The Top Line': What makes the Fierce 15 honorees tick, Fierce Biotech Summit's spotlight on gene editing and the bear market NewsRob MaguireSeptember 30, 2022
